These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15719455)

  • 81. Reforming pharmaceutical industry-physician financial relationships: lessons from the United States, France, and Japan.
    Rodwin MA
    J Law Med Ethics; 2011; 39(4):662-70. PubMed ID: 22084852
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
    Mehta RS
    Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
    [No Abstract]   [Full Text] [Related]  

  • 83. Academic medical centers and conflicts of interest.
    Watson PY; Musial JL; Khandewal AK; Buckley JD
    JAMA; 2006 Jun; 295(24):2847-8; author reply 2848-9. PubMed ID: 16804147
    [No Abstract]   [Full Text] [Related]  

  • 84. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 85. The Royal Australasian College of Physicians and the pharmaceutical industry.
    Woodruff T
    Intern Med J; 2007 Mar; 37(3):212. PubMed ID: 17316353
    [No Abstract]   [Full Text] [Related]  

  • 86. Banning pens and pads misses the main point.
    Terry SF; Burke W
    Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
    [No Abstract]   [Full Text] [Related]  

  • 87. Ethical issues associated with gifts provided to physicians by the pharmaceutical industry.
    Komesaroff PA
    Intern Med J; 2010 May; 40(5):321-2. PubMed ID: 20575991
    [No Abstract]   [Full Text] [Related]  

  • 88. Drug companies and clinical psychology.
    Baker E; Newnes C; Myatt H
    Ethical Hum Sci Serv; 2003; 5(3):247-53. PubMed ID: 15139338
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Physician-industry relations--will fewer gifts make a difference?
    Steinbrook R
    N Engl J Med; 2009 Feb; 360(6):557-9. PubMed ID: 19196671
    [No Abstract]   [Full Text] [Related]  

  • 90. How do we guarantee trainee professional purity?
    Jones JW; McCullough LB
    J Vasc Surg; 2009 Mar; 49(3):790-1. PubMed ID: 19268782
    [No Abstract]   [Full Text] [Related]  

  • 91. Cheap trinkets, effective marketing: small gifts from drug companies to physicians.
    Brett AS
    Am J Bioeth; 2003; 3(3):52-4. PubMed ID: 14594493
    [No Abstract]   [Full Text] [Related]  

  • 92. Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement.
    Moynihan R
    BMJ; 2003 May; 326(7400):1193-6. PubMed ID: 12775622
    [No Abstract]   [Full Text] [Related]  

  • 93. Interaction between optometrists and industry representatives.
    Optometry; 2009 Mar; 80(3):149-53. PubMed ID: 19271358
    [No Abstract]   [Full Text] [Related]  

  • 94. The Sunshine Act: how to avoid getting burned.
    Hurd P
    Fam Pract Manag; 2013; 20(5):8-10. PubMed ID: 24134101
    [No Abstract]   [Full Text] [Related]  

  • 95. Doctors and the drug industry: reader feedback.
    Warrier R; Houghton B
    Am J Med; 2005 Oct; 118(10):1175-6; author reply 1176. PubMed ID: 16194656
    [No Abstract]   [Full Text] [Related]  

  • 96. Charities and patient groups should declare interests.
    Hirst J
    BMJ; 2003 May; 326(7400):1211. PubMed ID: 12775630
    [No Abstract]   [Full Text] [Related]  

  • 97. A perspective on commercial relationships between ophthalmology and industry.
    Jampol LM; Packer S; Mills RP; Day SH; Lichter PR;
    Arch Ophthalmol; 2009 Sep; 127(9):1194-202. PubMed ID: 19752430
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Coffers brimming, ethically bankrupt.
    Solomon RC
    Ann Emerg Med; 2012 Feb; 59(2):101-2. PubMed ID: 22078890
    [No Abstract]   [Full Text] [Related]  

  • 99. Limiting gifts, harming patients.
    Rubin PH
    Ann Emerg Med; 2012 Feb; 59(2):99-100. PubMed ID: 21962876
    [No Abstract]   [Full Text] [Related]  

  • 100. [Case: bioethical disputes of the donations of the pharmaceutical companies to the health centers].
    González-González A
    Cuad Bioet; 2020; 31(103):423-427. PubMed ID: 33375807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.